Andrew Hertler, M.D., chief medical officer emeritus at Evolent, discusses the results of a recent paper in the Journal of ...

According to the American Cancer Society, it is estimated that more than two million new cancer cases will be diagnosed and ...

Multidisciplinary efforts help promote the success of clinical trials and innovation for patients with various forms of ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Neurosurgery experts from UCSF Health will present new research and clinical findings at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Boston, April 25-28.

Blocking this target has been shown to increase DNA damage, replication stress and tumour cell death in these tumour cells, and a “clear benefit” of the approach is that it does not affect healthy ...

which is site-specifically conjugated at glycan to the monomethyl auristatin E (MMAE) payload with a drug-to-antibody ratio (DAR) of 4. Elevation Oncology designed EO-1022 leveraging the site ...

Caribou Biosciences plans to trim its workforce and shift its pipeline as it looks to focus on its lead oncology programs. The Berkeley, Calif.-biopharmaceutical company on Thursday said it plans ...

This new edition reflects cutting-edge advancements in the field, and promises to be an essential resource for students, residents, and practitioners of radiation oncology. In-depth updates on ...

Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer therapies for tumours that rely on the alternative lengthening of ...

More information: Matrix M. H. Fung et al, Developing a named entity framework for thyroid cancer staging and risk level classification using large language models, npj Digital Medicine (2025).